EHA Library - The official digital education library of European Hematology Association (EHA)

DETECTION OF FLT3-INTERNAL TANDEM DUPLICATION WITH NGS: A COMPARISON OF DIFFERENT ANALYTICAL TOOLS.
Author(s): ,
Marie Le Mercier
Affiliations:
Laboratory of Hematology,Antwerp University Hospital,Edegem,Belgium
,
Katrien Vermeulen
Affiliations:
Laboratory of Hematology,Antwerp University Hospital,Edegem,Belgium
,
Christine Weyn
Affiliations:
Laboratory of Pathology,Antwerp University Hospital,Edegem,Belgium
,
Sarah Van Lent
Affiliations:
Laboratory of Hematology,Antwerp University Hospital,Edegem,Belgium
,
Daphné Lathauwers
Affiliations:
Laboratory of Hematology,Antwerp University Hospital,Edegem,Belgium
,
Chris De Beul
Affiliations:
Laboratory of Hematology,Antwerp University Hospital,Edegem,Belgium
,
Philip Holmgren
Affiliations:
ICT department,Antwerp University Hospital,Edegem,Belgium
,
Jan Van Den Bossche
Affiliations:
Laboratory of Hematology,Antwerp University Hospital,Edegem,Belgium
,
Ronald Malfait
Affiliations:
Laboratory of Hematology,Antwerp University Hospital,Edegem,Belgium
,
Kathleen Deiteren
Affiliations:
Laboratory of Hematology,Antwerp University Hospital,Edegem,Belgium
Marie-Berthe Maes
Affiliations:
Laboratory of Hematology,Antwerp University Hospital,Edegem,Belgium
(Abstract release date: 05/17/18) EHA Library. Le Mercier M. 06/14/18; 216212; PB1700
Marie Le Mercier
Marie Le Mercier
Contributions
Abstract

Abstract: PB1700

Type: Publication Only

Background

Internal tandem duplication (ITD) in the FLT3 tyrosine kinase gene is a somatic genetic alteration frequently found in acute myeloid leukemia (AML) and is associated with an aggressive phenotype. The accurate detection of FLT3-ITD together with evaluation of the mutant-to-wild-type allelic ratio are essential due to the strong prognostic and the potential therapeutic relevance of this marker in AML. The gold standard method for the detection of FLT3-ITD consists of PCR and electrophoresis-based product sizing. In the last years, as the number of relevant genetic alterations in myeloid neoplasm is increasing, next generation sequencing (NGS) has started to replace the conventional PCR methods in clinical diagnostic labs. However, NGS methods are usually not very performant for the detection of medium sized or long insertions or deletions.

Aims

The aim of this study was to evaluate the possibility to use NGS for accurate detection of FLT3-ITD in the daily practice.

Methods

We have developed a custom Haloplex NGS panel (Agilent) to sequence 29 genes related to myeloid neoplasm, among which FLT3 exons 14, 15 and 20. We used this panel on a MiSeq (Illumina) sequencing platform on 40 AML samples (23 FLT-ITD negative samples and 17 FLT-ITD positive samples) and compared the performance for FLT3-ITD detection of several analysis tools, both technical (different sequencing cartridges and analytical (Pindel, SOPHiA DDM and SeqNext).

Results

Best results for FLT3-ITD detection were obtained using 500v2 cartridge instead of 300v2. Regarding analysis software Pindel and SOPHiA DDM gave the best results in terms of detection (more than 88%). However, large differences were observed between NGS and fragment analysis regarding the mutant-to-wild-type ratio.

Conclusion

These results demonstrate that FLT3-ITD can be detected reliably with NGS. However, optimization is still needed to accurately determine the mutant-to-wild-type ratio since this ratio is an important aspect of the prognostic value of FLT3-ITD.

Session topic: 3. Acute myeloid leukemia - Biology & Translational Research

Keyword(s): Flt3-ITD

Abstract: PB1700

Type: Publication Only

Background

Internal tandem duplication (ITD) in the FLT3 tyrosine kinase gene is a somatic genetic alteration frequently found in acute myeloid leukemia (AML) and is associated with an aggressive phenotype. The accurate detection of FLT3-ITD together with evaluation of the mutant-to-wild-type allelic ratio are essential due to the strong prognostic and the potential therapeutic relevance of this marker in AML. The gold standard method for the detection of FLT3-ITD consists of PCR and electrophoresis-based product sizing. In the last years, as the number of relevant genetic alterations in myeloid neoplasm is increasing, next generation sequencing (NGS) has started to replace the conventional PCR methods in clinical diagnostic labs. However, NGS methods are usually not very performant for the detection of medium sized or long insertions or deletions.

Aims

The aim of this study was to evaluate the possibility to use NGS for accurate detection of FLT3-ITD in the daily practice.

Methods

We have developed a custom Haloplex NGS panel (Agilent) to sequence 29 genes related to myeloid neoplasm, among which FLT3 exons 14, 15 and 20. We used this panel on a MiSeq (Illumina) sequencing platform on 40 AML samples (23 FLT-ITD negative samples and 17 FLT-ITD positive samples) and compared the performance for FLT3-ITD detection of several analysis tools, both technical (different sequencing cartridges and analytical (Pindel, SOPHiA DDM and SeqNext).

Results

Best results for FLT3-ITD detection were obtained using 500v2 cartridge instead of 300v2. Regarding analysis software Pindel and SOPHiA DDM gave the best results in terms of detection (more than 88%). However, large differences were observed between NGS and fragment analysis regarding the mutant-to-wild-type ratio.

Conclusion

These results demonstrate that FLT3-ITD can be detected reliably with NGS. However, optimization is still needed to accurately determine the mutant-to-wild-type ratio since this ratio is an important aspect of the prognostic value of FLT3-ITD.

Session topic: 3. Acute myeloid leukemia - Biology & Translational Research

Keyword(s): Flt3-ITD

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies